1.
Franck E. Nicolini, H. Jean Khoury, Luke Akard, Delphine Rea, Hagop Kantarjian, Michele Baccarani, Janis Leonoudakis, Adam Craig, Annie-Claude Benichou, Jorge Cortes. Omacetaxine mepesuccinate for patients with accelerated phase chronic myeloid leukemia with resistance or intolerance to two or more tyrosine kinase inhibitors. haematol [Internet]. 2013Jul.1 [cited 2022Oct.6];98(7):e78-e79. Available from: https://haematologica.org/article/view/6737